BioSpace News Archive

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high quality cannabis, announced its financial results for the third quarter ended November 30, 2019.

HALO Dx, Inc., a rapid growth technology company headquartered in Silicon Valley, has brought together top technology experts with leading radiologists to set the new standard of care for the industry.

AVITA Medical Limited, a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, reported financial results for the fiscal second quarter ended 31 December 2019 in its Appendix 4C - Quarterly Cash Flow Report filed with the Australian Securities Exchange.

1Life Healthcare, Inc. announced the pricing of its initial public offering of 17,500,000 shares of common stock at a price of $14.00 per share for gross proceeds of $245 million, before deducting underwriting discounts and commissions and offering expenses payable by One Medical.

Itamar Medical Ltd. announced the upsizing and pricing of its public offering of 2,545,450 American Depositary Shares at a public offering price of $13.75 per ADS, for total gross proceeds of approximately $35.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Itamar Medical.

Jan. 31, 2020 01:52 UTC Not for Dissemination in the United States or for Distribution to U.S. Newswire Services MISSISSAUGA, Ontario--( BUSINESS WIRE )-- MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V:MDX) is pleased to announce that it has received Conditional Approval from the TSX Venture Exchange for a non-brokered Private Placement to accredited investors of up to 25,000,000 units at $0.12 per unit (“Unit”), to raise up to $3,000,000.

vasopharm GmbH, a privately held biopharmaceutical company focusing on novel therapeutics for the treatment of cerebrovascular diseases, is pleased to announce that enrolment into the pivotal European NOSTRA III (NO Synthase in TRAumatic Brain Injury) clinical trial is completed.

EyeTech Digital Systems, a global leader of Health AI, announces the launch of EyeOn, an all-in-one, ultra-slim eye gaze tablet during this year’s Assistive Technology Industry Association conference in Orlando, FL

Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, announces a trading update for the year ended 31 December 2019.

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has stepped up its efforts in enabling the development of multiple neutralizing antibodies for Novel Coronavirus (2019-nCoV) with its integrated technology platforms.